605
Participants
Start Date
January 31, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
March 31, 2014
Daclatasvir
Film-coated tablet, oral, 60 mg, once daily, 24 weeks
Telaprevir
Film-coated tablet, oral, 750 mg, 3 times daily
Peginterferon alfa-2a
Solution for injection, subcutaneous injection, 180 μg, weekly
Ribavirin
Film-coated tablet, oral, in a body weight stratified dose range of 1000-1200 mg per day
Local Institution, Vienna
Local Institution, Vienna
Local Institution, Prov. Buenos Aires
Local Institution, Prov de Santa Fe
Local Institution, Camperdown
Local Institution, Westmead Nsw
Local Institution, Hvidovre
Local Institution, Penrith
Local Institution, Prahran
Local Institution, Linz
Local Institution, Greenslopes Qld
Local Institution, Adelaide
Local Institution, Odense
Local Institution, Zurich
Weill Cornell Medical College, New York
Local Institution, Torino
Local Institution, Berlin
Local Institution, Safed
Local Institution, Berlin
Local Institution, Nazareth
Albert Einstein Medical Center, Philadelphia
Local Institution, Hamburg
Johns Hopkins University, Lutherville
Local Institution, Bergamo
Local Institution, Besançon
Duke University Medical Center, Durham
Carolinas Medical Center, Charlotte
Local Institution, Alcorcón
Gastrointestinal Specialists Of Georgia, Marietta
Atlanta Medical Center, Atlanta
Local Institution, Hanover
Local Institution, Haifa
Orlando Immunology Center, Orlando
Local Institution, Pessac
The Kirklin Clinic, Birmingham
Local Institution, Grenoble
Local Institution, Essen
Local Institution, Valencia
Local Institution, Florence
Local Institution, Cologne
Minnesota Gastroenterology, P.A., Saint Paul
Local Institution, Cisanello (pisa)
Local Institution, Lille
Local Institution, Frankfurt
Northwestern University, Chicago
Rush University Medical Center, Chicago
Saint Louis University Gastroenterology & Hepatology, St Louis
Local Institution, Tel Aviv
Local Institution, Strasbourg
Local Institution, Paris
Local Institution, Paris
Baylor College Of Medicine, Houston
Research Specialists Of Texas, Houston
Alamo Medical Research, San Antonio
Brooke Army Medical Center, Fort Sam Houston
Local Institution, Freiburg im Breisgau
Local Institution, Napoli
Mayo Clinic Arizona, Phoenix
Va Long Beach Healthcare System, Long Beach
Medical Associates Research Group, San Diego
Local Institution, Bondy
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Moscow
Yale University School Of Medicine, New Haven
University Of Maryland, Baltimore
University Of North Carolina At Chapel Hill School Of Med, Chapel Hill
University Gastroenterology, Providence
The Miriam Hospital, Providence
Local Institution, Ciudad de Buenos Aires
Local Institution, Ciudad de Buenos Aires
Local Institution, Fitzroy
Local Institution, São Paulo
Local Institution, Calgary
Local Institution, Edmonton
Local Institution, Vancouver
Local Institution, Winnipeg
Local Institution, Ottawa
Local Institution, Toronto
Local Institution, Bialystok
Local Institution, Chorzów
Local Institution, Kielce
Local Institution, Mysłowice
Local Institution, Racibórz
Local Institution, Wroclaw
Local Institution, Barcelona
Local Institution, Barcelona
Local Institution, London
Local Institution, Edinburgh
Local Institution, Glasgow
Local Institution, Birmingham
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY